Prosthetic Heart Valves Market

Prosthetic Heart Valves Market - Size, Share,
Growth, Outlook, and Opportunity Analysis,
Heart valves play an important role in controlling the blood flow to and from the heart. The heart
consists of four main types of valves that are tricuspid, pulmonary, mitral, and aortic valves.
Prosthetic heart valves are commonly known as artificial valves that implanted in the heart of the
patients suffering from the valvular heart disease. Thus, the surging incidence of heart disorders
drives the prosthetic heart valve market over the forecast period. There are 3 types of prosthetic heart
valve such as mechanical heart valve, tissue heart valve, and transcatheter heart valve.
Request Sample Copy of Research Report:
Market Dynamics
The aging population and increasing patient population of heart disease are expected to drive
demand for prosthetic heart valve-based treatment in the future. For instance, According to the
statistics of World Health Organization in 2012, 17.6 million people died of cardiovascular
disease (CVD) worldwide, and proportionally, this accounts for 31.43% of global mortality.
Moreover, The emergence of valve-in-valve procedures serves as a significant market
opportunity for the prosthetic heart valve.
Growing Aging Population and prevalence of valvular disease spur growth of the
prosthetic heart valve market
Increasing geriatric population and prevalence of valvular heart disease will boost the demand of
prosthetic heart valves market. According to the National Centre for Health Statistics, 2011,
Heart disease is the leading cause of death in the U.S., killing more than 600,000 Americans
each year. Continue focusing to advance surgical replacement technologies for patients with
diseased, damaged or malfunctioning heart valves by manufacturers is expected to create a
lucrative opportunities for the market over the forecast period. For instance, in 2017, Edwards
Lifesciences Corporation received U.S. FDA approval for aortic and mitral valve-in-valve
procedures using the Edwards SAPIEN 3 transcatheter heart valve. The SAPIEN 3 valve is the first
transcatheter heart valve approved in the U.S. for the treatment of both aortic and mitral
patients who are at high risk for a subsequent open-heart surgery to replace their bioprosthetic
valve. On the contrary, the high costs associated with the devices mainly transcatheter aortic
valve replacement devices and stringent government regulations may hamper the growth of the
Report includes chapters which deeply display the following deliverable about industry :
• Prosthetic Heart Valves Market Research Objective and Assumption
• Prosthetic Heart Valves Market Purview - Report Description, Executive Summary, and Coherent
Opportunity Map (COM)
• Prosthetic Heart Valves Market Dynamics, Regulations, and Trends Analysis - Market Dynamics,
Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value
Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Prosthetic Heart Valves Market, By Regions
• Prosthetic Heart Valves Market Competition by Manufacturers including Production, Share,
Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Prosthetic Heart Valves Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Prosthetic Heart Valves Market Manufacturing Cost Analysis including Key Raw Materials and Key
Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning
and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Prosthetic Heart Valves Market Forecast including Production, Consumption, Import and Export
Forecast by Type, Applications and Region.
• Research Findings and Conclusion
The key players operating in the global prosthetic heart valves market include Boston
Scientific Corporation, Edwards Lifesciences Corporation, Medtronic plc, LivaNova PLC,
Abbott, Jenavalve Technology, Inc., Lepu Medical Technology Co., Ltd., CryoLife, Inc., and
Neovasc Inc.
Inquire Here Before Purchase:
Detailed Segmentation:
• Global Prosthetic Heart Valves Market, By Product Type:
• Transcatheter Heart Valves
• Mechanical Heart Valves
• Tissue Heart Valves
• Global Prosthetic Heart Valves Market, By End User:
• Hospitals
• Ambulatory Surgical Centers
• Global Prosthetic Heart Valves Market, By Geography:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East
• Africa
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]